These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 10510332

  • 1. VEGF(165) mediates glomerular endothelial repair.
    Ostendorf T, Kunter U, Eitner F, Loos A, Regele H, Kerjaschki D, Henninger DD, Janjic N, Floege J.
    J Clin Invest; 1999 Oct; 104(7):913-23. PubMed ID: 10510332
    [Abstract] [Full Text] [Related]

  • 2. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.
    Masuda Y, Shimizu A, Mori T, Ishiwata T, Kitamura H, Ohashi R, Ishizaki M, Asano G, Sugisaki Y, Yamanaka N.
    Am J Pathol; 2001 Aug; 159(2):599-608. PubMed ID: 11485918
    [Abstract] [Full Text] [Related]

  • 3. A study of VEGF and its receptors in two rat models of proteinuria.
    Kanellis J, Levidiotis V, Khong T, Cox AJ, Stacker SA, Gilbert RE, Cooper ME, Power DA.
    Nephron Physiol; 2004 Aug; 96(1):P26-36. PubMed ID: 14752241
    [Abstract] [Full Text] [Related]

  • 4. Extracellular actin impairs glomerular capillary repair in experimental mesangioproliferative glomerulonephritis.
    Janssen U, Eitner F, Kunter U, Ostendorf T, Wolf G, Chaponnier C, Gabbiani G, Kerjaschki D, Floege J.
    Nephron Exp Nephrol; 2003 Aug; 93(4):e158-67. PubMed ID: 12759577
    [Abstract] [Full Text] [Related]

  • 5. A novel, dual role of CCN3 in experimental glomerulonephritis: pro-angiogenic and antimesangioproliferative effects.
    van Roeyen CR, Boor P, Borkham-Kamphorst E, Rong S, Kunter U, Martin IV, Kaitovic A, Fleckenstein S, Perbal B, Trautwein C, Weiskirchen R, Ostendorf T, Floege J.
    Am J Pathol; 2012 May; 180(5):1979-90. PubMed ID: 22538190
    [Abstract] [Full Text] [Related]

  • 6. Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy.
    Kim YG, Suga SI, Kang DH, Jefferson JA, Mazzali M, Gordon KL, Matsui K, Breiteneder-Geleff S, Shankland SJ, Hughes J, Kerjaschki D, Schreiner GF, Johnson RJ.
    Kidney Int; 2000 Dec; 58(6):2390-9. PubMed ID: 11115072
    [Abstract] [Full Text] [Related]

  • 7. Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy.
    Keller K, Daniel C, Schöcklmann H, Endlich KH, Kerjaschki D, Johnson RJ, Hugo C.
    Nephrol Dial Transplant; 2006 Oct; 21(10):2724-35. PubMed ID: 16861242
    [Abstract] [Full Text] [Related]

  • 8. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
    Zoja C, Abbate M, Corna D, Capitanio M, Donadelli R, Bruzzi I, Oldroyd S, Benigni A, Remuzzi G.
    Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
    [Abstract] [Full Text] [Related]

  • 9. [VEGF is an essential molecule for glomerular endothelial cells and its excretion in urine might be a unique marker of glomerular injury].
    Kitamoto Y, Tokunaga H, Miyamoto K, Tomita K.
    Rinsho Byori; 2000 Jun; 48(6):485-90. PubMed ID: 10897664
    [Abstract] [Full Text] [Related]

  • 10. Infusion of angiotensin II reduces loss of glomerular capillary area in the early phase of anti-Thy-1.1 nephritis possibly via regulating angiogenesis-associated factors.
    Takazawa Y, Maeshima Y, Kitayama H, Yamamoto Y, Kawachi H, Shimizu F, Matsui H, Sugiyama H, Yamasaki Y, Makino H.
    Kidney Int; 2005 Aug; 68(2):704-22. PubMed ID: 16014048
    [Abstract] [Full Text] [Related]

  • 11. Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis.
    Iruela-Arispe L, Gordon K, Hugo C, Duijvestijn AM, Claffey KP, Reilly M, Couser WG, Alpers CE, Johnson RJ.
    Am J Pathol; 1995 Dec; 147(6):1715-27. PubMed ID: 7495296
    [Abstract] [Full Text] [Related]

  • 12. Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo.
    Hugo CP, Pichler RP, Schulze-Lohoff E, Pröls F, Adler S, Krutsch HC, Murphy-Ullrich JE, Couser WG, Roberts DD, Johnson RJ.
    Kidney Int; 1999 Jun; 55(6):2236-49. PubMed ID: 10354272
    [Abstract] [Full Text] [Related]

  • 13. PDGF-C mediates glomerular capillary repair.
    Boor P, van Roeyen CR, Kunter U, Villa L, Bücher E, Hohenstein B, Hugo CP, Eriksson U, Satchell SC, Mathieson PW, Eitner F, Floege J, Ostendorf T.
    Am J Pathol; 2010 Jul; 177(1):58-69. PubMed ID: 20489153
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of capillary repair in proliferative glomerulonephritis results in persistent glomerular inflammation with glomerular sclerosis.
    Masuda Y, Shimizu A, Kataoka M, Arai T, Ishikawa A, Du X, Saito SK, Aki K, Nagasaka S, Mii A, Fujita E, Fukuda Y.
    Lab Invest; 2010 Oct; 90(10):1468-81. PubMed ID: 20644521
    [Abstract] [Full Text] [Related]

  • 15. Recovery of damaged glomerular capillary network with endothelial cell apoptosis in experimental proliferative glomerulonephritis.
    Shimizu A, Masuda Y, Kitamura H, Ishizaki M, Sugisaki Y, Yamanaka N.
    Nephron; 1998 Oct; 79(2):206-14. PubMed ID: 9647502
    [Abstract] [Full Text] [Related]

  • 16. Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy.
    Suga S, Kim YG, Joly A, Puchacz E, Kang DH, Jefferson JA, Abraham JA, Hughes J, Johnson RJ, Schreiner GF.
    Kidney Int; 2001 Oct; 60(4):1297-308. PubMed ID: 11576344
    [Abstract] [Full Text] [Related]

  • 17. Intrarenal injection of bone marrow-derived angiogenic cells reduces endothelial injury and mesangial cell activation in experimental glomerulonephritis.
    Uchimura H, Marumo T, Takase O, Kawachi H, Shimizu F, Hayashi M, Saruta T, Hishikawa K, Fujita T.
    J Am Soc Nephrol; 2005 Apr; 16(4):997-1004. PubMed ID: 15744001
    [Abstract] [Full Text] [Related]

  • 18. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis.
    Kunter U, Rong S, Djuric Z, Boor P, Müller-Newen G, Yu D, Floege J.
    J Am Soc Nephrol; 2006 Aug; 17(8):2202-12. PubMed ID: 16790513
    [Abstract] [Full Text] [Related]

  • 19. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C, Corna D, Bruzzi I, Foglieni C, Bertani T, Remuzzi G, Benigni A.
    Exp Nephrol; 1996 Aug; 4(4):213-21. PubMed ID: 8983642
    [Abstract] [Full Text] [Related]

  • 20. Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: therapeutic efficacy and safety.
    Burg M, Ostendorf T, Mooney A, Koch KM, Floege J.
    Lab Invest; 1997 Apr; 76(4):505-16. PubMed ID: 9111513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.